机构:[1]Medical Science Research Center,Zhongnan Hospital of Wuhan University,China[2]Institute of Model Animal,Wuhan University,China[3]Basic Medical School,Wuhan University,China[4]Department of Cardiology,Renmin Hospital of Wuhan University,China[5]Departments of Neonatology,Renmin Hospital of Wuhan University,China[6]Department of Cardiology,The Third Xiangya Hospital,Central South University,Changsha,China[7]Department of Emergency Medicine,Thomas Jefferson University,Philadelphia,Pennsylvania[8]Centre for Clinic Pharmacology,The William Harvey Research Institute,Queen Mary University of London,United Kingdom[9]Department of Neurology,The First People’s Hospital of Jingmen affiliated to Hubei Minzu University,Jingmen,China[10]Department of Hepatobiliary Surgery,The First Affiliated Hospital of Changjiang University,Jingzhou,China[11]Department of Hepatobiliary Surgery,Jingzhou Central Hospital,China[12]Department of Hepatobiliary and Pancreatic Surgery,Xianning Central Hospital,Hubei Province,China[13]Xiangyang Central Hospital,Affiliated Hospital of Hubei University of Arts and Science,China[14]Department of Hepatobiliary and Pancreatic Surgery,Suizhou central Hospital Affiliated to Hubei Medical College,China[15]Department of Cardiology,The First College of Clinical Medical Science,China Three Gorges University & Yichang Central People’s Hospital and Institute of Cardiovascular Diseases,China Three Gorges University[16]Department of Gastroenterology,Wuhan Third Hospital & Tongren Hospital of Wuhan University,China[17]Department of Hepatobiliary and Pancreatic Surgery,Zhongnan Hospital of Wuhan University,China[18]Division of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China华中科技大学同济医学院附属同济医院[19]Division of Cardiology,Department of Medicine,University of Ottawa Heart Institute,ON,Canada[20]Departments of Anesthesiology,Physiology and Medicine,Cardiovascular Research Laboratories,David Geffen School of Medicine,University of California,Los Angeles[21]Department of Cardiovascular Surgery,Union Hospital of Wuhan,Tongji Medical College,Huazhong University of Science and Technology,China华中科技大学同济医学院附属协和医院
第一作者机构:[1]Medical Science Research Center,Zhongnan Hospital of Wuhan University,China[2]Institute of Model Animal,Wuhan University,China[3]Basic Medical School,Wuhan University,China[4]Department of Cardiology,Renmin Hospital of Wuhan University,China
通讯作者:
通讯机构:[1]Medical Science Research Center,Zhongnan Hospital of Wuhan University,China[2]Institute of Model Animal,Wuhan University,China[3]Basic Medical School,Wuhan University,China[4]Department of Cardiology,Renmin Hospital of Wuhan University,China[*1]Medical Science Research Center,Zhongnan Hospital of Wuhan University,169 Donghu Rd,Wuhan,430072,China.
推荐引用方式(GB/T 7714):
Zhou Feng,Liu Ye-Mao,Xie Jing,et al.Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.[J].HYPERTENSION.2020,76(2):E15-E17.doi:10.1161/HYPERTENSIONAHA.120.15622.
APA:
Zhou Feng,Liu Ye-Mao,Xie Jing,Li Haomiao,Lei Fang...&Li Hongliang.(2020).Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality..HYPERTENSION,76,(2)
MLA:
Zhou Feng,et al."Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.".HYPERTENSION 76..2(2020):E15-E17